{"id":"https://openalex.org/W2952596923","doi":"https://doi.org/10.1177/1758835919856494","title":"Molecular targeted therapy of BRAF -mutant colorectal cancer","display_name":"Molecular targeted therapy of BRAF -mutant colorectal cancer","alternate_titles":[],"publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2952596923","doi":"https://doi.org/10.1177/1758835919856494","mag":"2952596923","pmid":"https://pubmed.ncbi.nlm.nih.gov/31244912","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6582307"},"language":"en","primary_location":{"id":"doi:10.1177/1758835919856494","doi":"https://doi.org/10.1177/1758835919856494","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1758835919856494","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2952596923"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1177/1758835919856494","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085121407","display_name":"Michel Pierre Ducreux","orcid":"https://orcid.org/0000-0001-8649-7449","observed_orcids":["https://orcid.org/0000-0001-8649-7449"]},"institutions":[{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michel Ducreux","raw_affiliation_strings":["D\u00e9partement d\u2019Oncologie M\u00e9dicale, Universit\u00e9 Paris-Saclay, Gustave Roussy Cancer Campus Grand Paris, 114 rue Edouard Vaillant, Villejuif Cedex, 94805, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019Oncologie M\u00e9dicale, Universit\u00e9 Paris-Saclay, Gustave Roussy Cancer Campus Grand Paris, 114 rue Edouard Vaillant, Villejuif Cedex, 94805, France","institution_ids":["https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040092926","display_name":"Ali N. Chamseddine","orcid":"https://orcid.org/0000-0001-5701-4268","observed_orcids":["https://orcid.org/0000-0001-5701-4268"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ali Chamseddine","raw_affiliation_strings":["D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France"],"raw_orcid":"https://orcid.org/0000-0001-5701-4268","affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089818289","display_name":"Pierre Laurent\u2010Puig","orcid":"https://orcid.org/0000-0001-8475-5459","observed_orcids":["https://orcid.org/0000-0001-8475-5459"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102325","display_name":"H\u00f4pital Europ\u00e9en Georges-Pompidou","ror":"https://ror.org/016vx5156","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102325","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]},{"id":"https://openalex.org/I4405261196","display_name":"M\u00e9decine Personnalis\u00e9e, Pharmacog\u00e9nomique, Optimisation Th\u00e9rapeutique","ror":"https://ror.org/04yb08h36","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4405261196"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Laurent-Puig","raw_affiliation_strings":["D\u00e9partement de Biologie, Assistance Publique H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Paris, France","Universit\u00e9 Paris-Descartes, Paris, France; INSERM UMRS-1147, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biologie, Assistance Publique H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210102325"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Descartes, Paris, France; INSERM UMRS-1147, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387156284","https://openalex.org/I4405261196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012527087","display_name":"Cristina Smolenschi","orcid":"https://orcid.org/0000-0002-7568-6196","observed_orcids":["https://orcid.org/0000-0002-7568-6196"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cristina Smolenschi","raw_affiliation_strings":["D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086593040","display_name":"Antoine Hollebecque","orcid":"https://orcid.org/0000-0003-2869-7551","observed_orcids":["https://orcid.org/0000-0003-2869-7551"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Antoine Hollebecque","raw_affiliation_strings":["D\u00e9partement d\u2019Innovation Th\u00e9rapeutique et des Essais Pr\u00e9coces (DITEP), Gustave Roussy Cancer Campus Grand Paris, Villejuif, France","D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019Innovation Th\u00e9rapeutique et des Essais Pr\u00e9coces (DITEP), Gustave Roussy Cancer Campus Grand Paris, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047997030","display_name":"Peggy Dartigues","orcid":"https://orcid.org/0009-0002-8383-3050","observed_orcids":["https://orcid.org/0009-0002-8383-3050"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Peggy Dartigues","raw_affiliation_strings":["D\u00e9partement de Biopathologie, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028431629","display_name":"Emmanuelle Samalin","orcid":"https://orcid.org/0009-0001-6997-6090","observed_orcids":["https://orcid.org/0009-0001-6997-6090"]},"institutions":[{"id":"https://openalex.org/I4387154388","display_name":"Institut Regional du Cancer de Montpellier","ror":"https://ror.org/02693j602","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emmanuelle Samallin","raw_affiliation_strings":["D\u00e9partement d\u2019Oncologie Digestive, Institut r\u00e9gional du Cancer de Montpellier (ICM), Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019Oncologie Digestive, Institut r\u00e9gional du Cancer de Montpellier (ICM), Montpellier, France","institution_ids":["https://openalex.org/I4387154388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041492973","display_name":"Val\u00e9rie Boige","orcid":"https://orcid.org/0000-0002-7817-4663","observed_orcids":["https://orcid.org/0000-0002-7817-4663"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Val\u00e9rie Boige","raw_affiliation_strings":["D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017132355","display_name":"David Malka","orcid":"https://orcid.org/0000-0002-7664-0130","observed_orcids":["https://orcid.org/0000-0002-7664-0130"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"David Malka","raw_affiliation_strings":["D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d\u2019Oncologie M\u00e9dicale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039672039","display_name":"Maximiliano Gelli","orcid":"https://orcid.org/0000-0001-9807-4021","observed_orcids":["https://orcid.org/0000-0001-9807-4021"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Maximiliano Gelli","raw_affiliation_strings":["D\u00e9partement de Chirurgie Visc\u00e9rale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Chirurgie Visc\u00e9rale, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5039672039"],"corresponding_institution_ids":["https://openalex.org/I2801843802"],"apc_list":{"value":2200,"currency":"USD","value_usd":2200},"apc_paid":{"value":2200,"currency":"USD","value_usd":2200},"fwci":1.906,"has_fulltext":true,"cited_by_count":113,"citation_normalized_percentile":{"value":0.88667017,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"11","issue":null,"first_page":"1758835919856494","last_page":"1758835919856494"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-mutant-colorectal-cancer","display_name":"BRAF-mutant colorectal cancer","score":0.8989999890327454},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9440000057220459},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.9750000238418579},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.8510000109672546},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9599999785423279},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.8709999918937683},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.7919999957084656},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.8109999895095825},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.800000011920929},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.8220000267028809},{"id":"https://openalex.org/keywords/folfoxiri","display_name":"FOLFOXIRI","score":0.6620000004768372},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9009724855422974},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8748710751533508},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.856611967086792},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8548471331596375},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.7060451507568359},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.683691143989563},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6641016006469727},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6483122110366821},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6107081174850464},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.5618581771850586},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5380297303199768},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.5188140273094177},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.49366793036460876},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4855439364910126},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.45332756638526917},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35545408725738525},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.34822946786880493},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.16147011518478394}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/1758835919856494","doi":"https://doi.org/10.1177/1758835919856494","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1758835919856494","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6582307","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6582307/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6582307/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Med Oncol","raw_type":"Text"},{"id":"pmid:31244912","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31244912","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in medical oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:718d9b09b2434cf48895df75199b4017","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/718d9b09b2434cf48895df75199b4017","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutic Advances in Medical Oncology, Vol 11 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/1758835919856494","doi":"https://doi.org/10.1177/1758835919856494","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1758835919856494","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2952596923.pdf","grobid_xml":"https://content.openalex.org/works/W2952596923.grobid-xml"},"referenced_works_count":98,"referenced_works":["https://openalex.org/W49408137","https://openalex.org/W151650441","https://openalex.org/W310635454","https://openalex.org/W1444268565","https://openalex.org/W1481372545","https://openalex.org/W1597604324","https://openalex.org/W1727309928","https://openalex.org/W1846586690","https://openalex.org/W1892665108","https://openalex.org/W1922733886","https://openalex.org/W1934094702","https://openalex.org/W1940241680","https://openalex.org/W1972301208","https://openalex.org/W1985199765","https://openalex.org/W1993780950","https://openalex.org/W2011851517","https://openalex.org/W2014881369","https://openalex.org/W2023046293","https://openalex.org/W2036045525","https://openalex.org/W2062289724","https://openalex.org/W2077428590","https://openalex.org/W2093272868","https://openalex.org/W2101144899","https://openalex.org/W2101987123","https://openalex.org/W2103547637","https://openalex.org/W2106543129","https://openalex.org/W2106845199","https://openalex.org/W2107421779","https://openalex.org/W2110682589","https://openalex.org/W2111404068","https://openalex.org/W2111905790","https://openalex.org/W2112327912","https://openalex.org/W2114486584","https://openalex.org/W2115735904","https://openalex.org/W2118017554","https://openalex.org/W2121545342","https://openalex.org/W2123965006","https://openalex.org/W2127094435","https://openalex.org/W2129998117","https://openalex.org/W2130921932","https://openalex.org/W2131413118","https://openalex.org/W2132598198","https://openalex.org/W2133523341","https://openalex.org/W2134142320","https://openalex.org/W2134519717","https://openalex.org/W2135800465","https://openalex.org/W2147001311","https://openalex.org/W2147873693","https://openalex.org/W2152454229","https://openalex.org/W2157137844","https://openalex.org/W2157210705","https://openalex.org/W2157769714","https://openalex.org/W2160766792","https://openalex.org/W2163188200","https://openalex.org/W2165562484","https://openalex.org/W2166262263","https://openalex.org/W2171576276","https://openalex.org/W2234830428","https://openalex.org/W2236349189","https://openalex.org/W2309935793","https://openalex.org/W2325192759","https://openalex.org/W2463198458","https://openalex.org/W2530590137","https://openalex.org/W2561040446","https://openalex.org/W2561667833","https://openalex.org/W2567259523","https://openalex.org/W2586254558","https://openalex.org/W2594373254","https://openalex.org/W2598954950","https://openalex.org/W2603299281","https://openalex.org/W2609927476","https://openalex.org/W2611286974","https://openalex.org/W2613375073","https://openalex.org/W2614470022","https://openalex.org/W2624834472","https://openalex.org/W2730259699","https://openalex.org/W2739132742","https://openalex.org/W2739964468","https://openalex.org/W2743800325","https://openalex.org/W2760461398","https://openalex.org/W2766092891","https://openalex.org/W2766962807","https://openalex.org/W2779489514","https://openalex.org/W2784868445","https://openalex.org/W2787981425","https://openalex.org/W2791410762","https://openalex.org/W2791557665","https://openalex.org/W2797024694","https://openalex.org/W2803281998","https://openalex.org/W2804969502","https://openalex.org/W2808859897","https://openalex.org/W2883420771","https://openalex.org/W2886047150","https://openalex.org/W2890872350","https://openalex.org/W3046986182","https://openalex.org/W4246064222","https://openalex.org/W4248090744","https://openalex.org/W4250745281"],"related_works":["https://openalex.org/W2951034455","https://openalex.org/W4414705371","https://openalex.org/W3141745744","https://openalex.org/W3083192158","https://openalex.org/W4225402509","https://openalex.org/W4377041775","https://openalex.org/W4312249116","https://openalex.org/W3148370335","https://openalex.org/W3132428231","https://openalex.org/W3005340960"],"abstract_inverted_index":{"Over":[0],"the":[1,5,17,56,82,96,112,180,192,209,216,220,224],"past":[2],"two":[3,93],"decades,":[4],"molecular":[6],"characterization":[7],"of":[8,20,49,72,106,114,120,151,156,191,236],"metastatic":[9],"colorectal":[10],"cancer":[11],"(mCRC)":[12],"has":[13,167],"been":[14,177,198,231],"revolutionized":[15],"by":[16,219],"routine":[18],"implementation":[19],"RAS":[21],"and":[22,109,172,239],"BRAF":[23,37,165,183,195],"tests.":[24],"As":[25],"a":[26,40,66,102,148,234],"result,":[27],"it":[28,44],"is":[29,53,63,99,130],"now":[30],"known":[31],"that":[32,182],"patients":[33,75,152],"with":[34,65,111,164,200,233],"mCRC":[35],"harboring":[36],"mutations":[38],"experience":[39,154],"poor":[41,68],"prognosis.":[42,69],"Although":[43],"accounts":[45],"for":[46],"only":[47,55],"10%":[48],"mCRC,":[50],"this":[51,157,170],"group":[52],"heterogeneous;":[54],"BRAF-V600E":[57],"mutation,":[58],"also":[59,176],"observed":[60],"in":[61,144,169,227],"melanoma,":[62],"associated":[64],"very":[67],"In":[70,88],"terms":[71],"treatment,":[73],"these":[74,145,242],"do":[76],"not":[77,212],"benefit":[78],"from":[79],"therapeutics":[80],"targeting":[81],"epidermal":[83],"growth":[84],"factor":[85],"receptor":[86],"(EGFR).":[87],"first-line":[89,158],"chemotherapy,":[90],"there":[91],"are":[92,246],"main":[94],"options;":[95],"first":[97],"one":[98],"to":[100,131,140,188,215],"use":[101,132],"triple":[103],"chemotherapy":[104,134],"combination":[105,235],"5-fluorouracil,":[107],"irinotecan,":[108],"oxaliplatin,":[110],"addition":[113],"bevacizumab,":[115,136],"because":[116],"post":[117],"hoc":[118],"analysis":[119],"randomized":[121],"trials":[122],"have":[123,141,175,197,230],"reported":[124],"interesting":[125],"results.":[126],"The":[127],"other":[128],"option":[129],"double":[133],"plus":[135,203],"since":[137],"anti-EGFR":[138,201],"seems":[139],"modest":[142],"activity":[143],"patients.":[146],"Only":[147],"small":[149],"percentage":[150],"who":[153],"failure":[155],"treatment":[159,229],"receive":[160],"second-line":[161,228],"treatment.":[162],"Monotherapy":[163],"inhibitors":[166,196],"failed":[168],"setting,":[171],"different":[173],"combinations":[174],"tested.":[178],"Using":[179],"rationale":[181],"inhibitor":[184],"monotherapy":[185],"fails":[186],"due":[187],"feedback":[189],"activation":[190],"EGFR":[193],"pathway,":[194],"combined":[199],"agents":[202],"or":[204],"minus":[205],"MEK":[206],"inhibitors;":[207],"however,":[208],"results":[210,226],"did":[211],"live":[213],"up":[214],"hopes":[217],"raised":[218],"concept.":[221],"To":[222],"date,":[223],"best":[225],"obtained":[232],"vemurafenib,":[237],"cetuximab,":[238],"irinotecan.":[240],"Despite":[241],"advances,":[243],"further":[244],"improvements":[245],"needed.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2952596923","counts_by_year":[{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":27},{"year":2020,"cited_by_count":26},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-06-27T00:00:00"}
